Diagonal Bio AB (publ)

OM:DIABIO Stock Report

Market Cap: SEK 12.8m

Diagonal Bio Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Karin Wehlin

Chief executive officer

SEK 64.0k

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO

Karin Wehlin (61 yo)

less than a year

Tenure

SEK 64,000

Compensation

Ms. Karin Wehlin, MBA is Chief Executive Officer of Diagonal Bio AB (publ) since February 2024 and was its Director since 2023 until June 12, 2024 and served as its Interim CEO from November 23, 2023 to Fe...

Leadership Team

NamePositionTenureCompensationOwnership
Karin Wehlin
Chief Executive Officerless than a yearSEK 64.00kno data
Kushagr Punyani
Tech Advisorno dataSEK 100.00k0.50%
SEK 63.4k
Andreas Nyberg
Founder & Chief Scientific Officer4.8yrsno data0.23%
SEK 29.6k
Johan Kallstrand
Founding Partnerno datano datano data
Fata Mrsic
Chief Financial Officerless than a yearno datano data

0.8yrs

Average Tenure

Experienced Management: DIABIO's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Kushagr Punyani
Tech Advisor4.8yrsSEK 100.00k0.50%
SEK 63.4k
Kerstin Jakobsson
Chair of the Board3.8yrsSEK 212.00kno data
Sam Whitehouse
Member of Advisory Boardno datano datano data
Edvard Hall
Director3.8yrsno datano data
Tim Christensen
Member of Advisory Boardno datano datano data

3.8yrs

Average Tenure

39yo

Average Age

Experienced Board: DIABIO's board of directors are considered experienced (3.8 years average tenure).